{"id":139317,"date":"2014-09-04T21:56:20","date_gmt":"2014-09-05T01:56:20","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/skylits-handheld-device-could-bring-psoriasis-eczema-phototherapy-home.php"},"modified":"2014-09-04T21:56:20","modified_gmt":"2014-09-05T01:56:20","slug":"skylits-handheld-device-could-bring-psoriasis-eczema-phototherapy-home","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/psoriasis-2\/skylits-handheld-device-could-bring-psoriasis-eczema-phototherapy-home.php","title":{"rendered":"Skylits handheld device could bring psoriasis, eczema phototherapy home"},"content":{"rendered":"<p><p>    San Diego startup Skylit    Medical is developing a phototherapy device for private    home use to treat conditions like psoriasis, eczema and    vitiligo.Its one of thosenecessitys the mother of    inventionish stories  founder     Martyn Grosshimself has eczema and psoriasis.  <\/p>\n<p>    We are a frustrated group, because this is an inflammatory    condition for which there is no cure  so we spend $10 billion    per year to solve this problem, Gross said, adding that most    of these dollars go to systemic and biologic drugs, which are    costly out-of-pocket for patients.  <\/p>\n<p>    Indeed, onecommon therapy for these autoimmune skin    conditions is UVB therapy  but the problem for many patients,    Grosssaid, is that it takes a significant time investment    to regularly go to a phototherapy clinic.  <\/p>\n<p>    Skylits concept is todevelop its handheld device,    setting up an out-of-pocket subscription service for patients    to essentially lease it and use it at home. The patient would    receive a prescription from a dermatologist, and then the    doctor-programmed device would do the rest of the work. Itd    turn on the UVB light in, say, 30-second increments  whatever    and whenever the doctor orders  and then automatically shut    off once the days sufficient therapy has been administered.  <\/p>\n<p>    The goal is ultimately to build a camera into the device, so    that the skin conditions progression can be tracked by a derm.    In the near-term, the device will at least have WiFi and    Bluetooth capabilities to transmit prescription data from the    doc to the patient, Gross said.  <\/p>\n<p>    Phototherapy has, by the way, a range of benefits for skin    conditions, according    to the National Eczema Association  reducing itch, working    as an anti-inflammatory agent, increasing vitamin D production    and increasing bacteria-fighting systems in the skin. For    psoriasis and even vitiligo, it shows similar benefits.  <\/p>\n<p>    Skylit     isnt the only device, it should be noted, that is working    in the at-home phototherapy business. But thecompanys in    the midst of a $2 million seedround, having raised about    $150,000 by the end of July,     according to a regulatory filing. Gross said it hopes to    raise $3.4 million, however, in its Series A round.  <\/p>\n<p>    The goal with the Skylit device was to make it as easy as    possible, Gross said.  <\/p>\n<p>              Get our daily newsletter or follow us.            <\/p>\n<p>                Please enter your email below:              <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Continue reading here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/medcitynews.com\/2014\/09\/skylits-handheld-device-bring-psoriasis-eczema-phototherapy-home\" title=\"Skylits handheld device could bring psoriasis, eczema phototherapy home\">Skylits handheld device could bring psoriasis, eczema phototherapy home<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> San Diego startup Skylit Medical is developing a phototherapy device for private home use to treat conditions like psoriasis, eczema and vitiligo.Its one of thosenecessitys the mother of inventionish stories founder Martyn Grosshimself has eczema and psoriasis. We are a frustrated group, because this is an inflammatory condition for which there is no cure so we spend $10 billion per year to solve this problem, Gross said, adding that most of these dollars go to systemic and biologic drugs, which are costly out-of-pocket for patients <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/psoriasis-2\/skylits-handheld-device-could-bring-psoriasis-eczema-phototherapy-home.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[182497],"tags":[],"class_list":["post-139317","post","type-post","status-publish","format-standard","hentry","category-psoriasis-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/139317"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=139317"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/139317\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=139317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=139317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=139317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}